Literature DB >> 4026282

Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase.

F M Veronese, R Largajolli, E Boccù, C A Benassi, O Schiavon.   

Abstract

A single-step method of activation of monomethoxypolyethylene glycols suitable for its binding to polypeptides and proteins is proposed. Based on the reaction with 2,4,5-trichlorophenylchloroformate or p-nitrophenylchloroformate, it gives reactive PEG-phenylcarbonate derivatives. The PEG intermediate is stable on storage, the activating group is easily quantified,and the reaction with amino acid and proteins proceeds rapidly at pH near neutrality. The PEG derivatization of enzymes with this procedure is less inactivating than those previously reported. Ribonuclease and superoxide dismutase were modified and the effect of (a) bound polymer on clearance time in rats, (b) antibody recognition, and (c) on the enzymatic activity toward low and high molecular weight substrates were studied.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026282     DOI: 10.1007/bf02798546

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  12 in total

1.  An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

Authors:  S L Snyder; P Z Sobocinski
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

2.  Soluble dextran-hemoglobin complex as a potential blood substitute.

Authors:  S C Tam; J Blumenstein; J T Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters.

Authors:  F M Veronese; E Boccù; O Schiavon; G P Velo; A Conforti; L Franco; R Milanino
Journal:  J Pharm Pharmacol       Date:  1983-11       Impact factor: 3.765

5.  A method for the estimation of polyethylene glycol in plasma protein fractions.

Authors:  G E Sims; T J Snape
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Modification of amino groups in porcine pancreatic elastase with polyethylene glycol in relation to binding ability towards anti-serum and to enzymic activity.

Authors:  A Koide; S Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  1983-03-16       Impact factor: 3.575

7.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.

Authors:  A Abuchowski; J R McCoy; N C Palczuk; T van Es; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

8.  Stabilization of human beta-D-N-acetylhexosaminidase A towards proteolytic inactivation by coupling it to poly(N-vinylpyrrolidone).

Authors:  B Geiger; B U Von Specht; R Arnon
Journal:  Eur J Biochem       Date:  1977-02-15

9.  Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity.

Authors:  P S Pyatak; A Abuchowski; F F Davis
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-07

10.  Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.

Authors:  A Abuchowski; T van Es; N C Palczuk; F F Davis
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

View more
  10 in total

1.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

2.  Degradable PEGylated Protein Conjugates Utilizing RAFT Polymerization.

Authors:  Caitlin G Decker; Heather D Maynard
Journal:  Eur Polym J       Date:  2015-04-01       Impact factor: 4.598

3.  Glucose-binding property of pegylated concanavalin A.

Authors:  J J Kim; K Park
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

4.  Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG.

Authors:  D C Wylie; M Voloch; S Lee; Y H Liu; S Cannon-Carlson; C Cutler; B Pramanik
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

5.  "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.

Authors:  M A Croyle; N Chirmule; Y Zhang; J M Wilson
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Poly(ethylene glycol) hydrogels with cell cleavable groups for autonomous cell delivery.

Authors:  Mrityunjoy Kar; Yu-Ru Vernon Shih; Daniel Ortiz Velez; Pedro Cabrales; Shyni Varghese
Journal:  Biomaterials       Date:  2015-11-10       Impact factor: 12.479

7.  Comparative kinetic study between native and chemically modified Cu,Zn superoxide dismutases.

Authors:  E Argese; R Girotto; E F Orsega
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

8.  Altered biodistribution of an antibody--enzyme conjugate modified with polyethylene glycol.

Authors:  E A Eno-Amooquaye; F Searle; J A Boden; S K Sharma; P J Burke
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

9.  PEGylation and antioxidant effects of a human glutathione peroxidase 1 mutant.

Authors:  Guang-Yuan Zhang; Yan-Wei Wang; Li-Ying Guo; Liang-Ru Lin; Shao-Peng Niu; Chang-Hao Xiong; Jing-Yan Wei
Journal:  Aging (Albany NY)       Date:  2022-01-12       Impact factor: 5.682

10.  Protein-polymer bioconjugates via a versatile oxygen tolerant photoinduced controlled radical polymerization approach.

Authors:  Alexis Theodorou; Evelina Liarou; David M Haddleton; Iren Georgia Stavrakaki; Panagiotis Skordalidis; Richard Whitfield; Athina Anastasaki; Kelly Velonia
Journal:  Nat Commun       Date:  2020-03-20       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.